Zobrazeno 1 - 10
of 25
pro vyhledávání: '"I V, Kukes"'
Autor:
M. V. Zamergrad, V. A. Parfenov, O. D. Ostroumova, A. L. Guseva, O. V. Zaytseva, Yu. P. Sivolap, I. V. Kukes, V. A. Voronov
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 4, Pp 4-13 (2024)
Functional dizziness (FD) is the most common form of chronic dizziness, accounting for up to 20% of all cases of chronic dizziness and is diagnosed in 40% of patients referred to specialized clinics. This article discusses the pathogenesis, clinical
Externí odkaz:
https://doaj.org/article/a6562278eee74e89915173dda7b74a51
Publikováno v:
Медицинский совет, Vol 0, Iss 8, Pp 49-55 (2022)
Introduction. With an increase in the level of acquired antibiotic resistance of pathogens, treatment becomes more complicated and slows down, especially in infections associated with biofilms. There is a growing need for the development and use of n
Externí odkaz:
https://doaj.org/article/0614250c4a4b4fe296b6c003c5fefcaf
Autor:
V. F. Bezhenar, O. L. Molchanov, I. V. Kukes, A. A. Meznikov, L. A. Galiullina, A. Yu. Zosimovskiy, A. L. Poznyak
Publikováno v:
Медицинский совет, Vol 0, Iss 13, Pp 207-215 (2021)
Introduction. Infectious inflammatory and dysbiotic diseases of the vagina represent a major concern facing obstetric and gynecological science. Individually, the two most common specific diseases can be distinguished, namely: bacterial vaginosis (BV
Externí odkaz:
https://doaj.org/article/836cd8e53439495eb1f2f53bc63e40e4
Autor:
D. V. Blinov, E. S. Akarachkova, V. I. Tsibizova, D. I. Korabelnikov, N. V. Pavlova, I. V. Kukes, D. A. Petrenko
Publikováno v:
Эпилепсия и пароксизмальные состояния, Vol 13, Iss 3, Pp 254-263 (2021)
In 2019, some restrictions for use of valproic acid in women with reproductive potential by regulatory authorities and the original drug manufacturer based on the results of studies in real clinical practice were introduced. During 2019–2021, there
Externí odkaz:
https://doaj.org/article/e1388c449c104153b78d0f6461e85a30
Autor:
I. V. Kukes, J. M. Salmasi, K. S. Ternovoy, A. N. Kazimirskii, T. E. Obodzinskaya, V. G. Lim, P. B. Glagovskiy, I. S. Mamedov, G. V. Poryadin, A. S. Savicheva, E. A. Kukes, M. S. Ptitsyn, A. D. Andreev
Publikováno v:
Медицинский совет, Vol 0, Iss 12, Pp 72-88 (2021)
SARS-CoV-2 is a novel coronavirus that has been identified as the cause of the 2019 coronavirus infection (COVID-19), which originated at Wuhan city of PRC in late 2019 and widespread worldwide. As the number of patients recovering from COVID-19 cont
Externí odkaz:
https://doaj.org/article/1c267a9d9fb644e4bdfee5cd11664e8e
Publikováno v:
Медицинский совет, Vol 0, Iss 12, Pp 181-191 (2021)
Respiratory diseases remain a common group of diseases in the practice of general physicians and pulmonologists. Currently, there are various treatment protocols for patients with respiratory diseases, where one of the pharmacological groups is mucol
Externí odkaz:
https://doaj.org/article/33d2f9795cab4f2fb7706e6d2480f1c0
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 210-220 (2021)
Nowadays pharmacological group classified by the ATX L03AX code as immunostimulants is demand among doctors of various specialties. The main area of application of such drugs is infectious respiratory viral processes, which are associated not only wi
Externí odkaz:
https://doaj.org/article/5128f28fc13b4459abd0b17e879d2c52
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 111-117 (2021)
Abstract Introduction. Considering the development of technologies and techniques, it is highly relevant today to continue studying the features of interaction of drugs developed and introduced into clinical practice in the 1960s and 1980s with the e
Externí odkaz:
https://doaj.org/article/69cdcb28b1ae49bbbf8f6acb05f10eea
Autor:
V. V. Lebedeva, I. T. Fedyakina, O. E. Latyshev, E. I. Burtseva, I. V. Kukes, D. V. Blinov, O. V. Eliseeva, V. F. Larichev, T. M. Garaev, T. V. Grebennikova
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 20, Iss 3, Pp 83-90 (2021)
Due to the emergence of a new coronavirus infection COVID-19, scientists around the world are actively working on a vaccine against the SARS-CoV-2 coronavirus. At the same time, it is possible that existing medications can help in the fight against t
Externí odkaz:
https://doaj.org/article/679afaf6943443ffb82113649e2b390b
Autor:
I. V. Kukes, V. G. Lim, K. A. Ivantsov, E. Yu. Solovyeva, L. P. Sokolova, I. R. Gilmutdinova, P. B. Glagovskiy, M. S. Ptitsyn
Publikováno v:
Meditsinskiy sovet = Medical Council. :57-64
Introduction. The material presents the results of the study of the effectiveness of the drug Ethylmethylhydroxypyridine malate in patients with long COVID, based on the dynamics of clinical manifestations and metabolomic parameters responsible for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::076c724fbe5cfeb71048994c8c24e11f
https://doi.org/10.21518/ms2023-111
https://doi.org/10.21518/ms2023-111